Innoviva, Inc. (INVA)
USD 17.16
(-2.0%)
USD 17.16
(-2.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 261.06 Million USD | -22.56% |
| 2022 | 317.54 Million USD | -16.0% |
| 2021 | 378.03 Million USD | 12.84% |
| 2020 | 335 Million USD | 28.35% |
| 2019 | 261.01 Million USD | 0.0% |
| 2018 | 261 Million USD | 20.91% |
| 2017 | 215.86 Million USD | 63.31% |
| 2016 | 132.17 Million USD | 157.5% |
| 2015 | 51.33 Million USD | 5389.84% |
| 2014 | 935 Thousand USD | 121.85% |
| 2013 | -4.28 Million USD | -103.35% |
| 2012 | 127.6 Million USD | 420.58% |
| 2011 | 24.51 Million USD | 1.19% |
| 2010 | 24.22 Million USD | -0.62% |
| 2009 | 24.37 Million USD | 5.53% |
| 2008 | 23.09 Million USD | 4.97% |
| 2007 | 22 Million USD | 12.33% |
| 2006 | 19.58 Million USD | 62.49% |
| 2005 | 12.05 Million USD | 34.83% |
| 2004 | 8.94 Million USD | 147.99% |
| 2003 | 3.6 Million USD | 2210.9% |
| 2002 | 156 Thousand USD | 0.0% |
| 2001 | - USD | 100.0% |
| 2000 | -43.18 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 84.96 Million USD | 41.53% |
| 2024 Q1 | 60.03 Million USD | -9.24% |
| 2023 Q1 | 66.02 Million USD | 18.55% |
| 2023 Q4 | 66.14 Million USD | 15.89% |
| 2023 Q3 | 57.07 Million USD | -20.74% |
| 2023 Q2 | 72.01 Million USD | 9.07% |
| 2023 FY | 245.91 Million USD | -22.56% |
| 2022 Q1 | 86.55 Million USD | -16.95% |
| 2022 Q4 | 55.69 Million USD | -12.41% |
| 2022 FY | 317.54 Million USD | -16.0% |
| 2022 Q3 | 63.57 Million USD | -39.24% |
| 2022 Q2 | 104.62 Million USD | 20.88% |
| 2021 FY | 378.03 Million USD | 12.84% |
| 2021 Q1 | 85.46 Million USD | -5.3% |
| 2021 Q3 | 97.41 Million USD | -3.33% |
| 2021 Q4 | 104.22 Million USD | 6.99% |
| 2021 Q2 | 100.76 Million USD | 17.9% |
| 2020 Q1 | 78.67 Million USD | 3.56% |
| 2020 FY | 335 Million USD | 28.35% |
| 2020 Q2 | 78.38 Million USD | -0.37% |
| 2020 Q3 | 87.68 Million USD | 11.86% |
| 2020 Q4 | 90.25 Million USD | 2.93% |
| 2019 Q4 | 75.97 Million USD | 15.54% |
| 2019 Q3 | 65.75 Million USD | 2.57% |
| 2019 Q2 | 64.1 Million USD | 16.17% |
| 2019 FY | 261.01 Million USD | 0.0% |
| 2019 Q1 | 55.18 Million USD | -30.9% |
| 2018 FY | 261 Million USD | 20.91% |
| 2018 Q4 | 79.85 Million USD | 29.47% |
| 2018 Q1 | 52.38 Million USD | -24.28% |
| 2018 Q2 | 67.08 Million USD | 28.08% |
| 2018 Q3 | 61.68 Million USD | -8.06% |
| 2017 Q2 | 58.21 Million USD | 45.03% |
| 2017 FY | 215.86 Million USD | 63.31% |
| 2017 Q4 | 69.17 Million USD | 43.13% |
| 2017 Q3 | 48.33 Million USD | -16.98% |
| 2017 Q1 | 40.13 Million USD | -7.23% |
| 2016 Q3 | 33.02 Million USD | 2.87% |
| 2016 Q4 | 43.26 Million USD | 31.02% |
| 2016 Q1 | 23.78 Million USD | 7.55% |
| 2016 Q2 | 32.1 Million USD | 34.97% |
| 2016 FY | 132.17 Million USD | 157.5% |
| 2015 Q4 | 22.11 Million USD | 69.91% |
| 2015 Q2 | 10.01 Million USD | 61.98% |
| 2015 Q1 | 6.18 Million USD | -12.8% |
| 2015 Q3 | 13.01 Million USD | 29.93% |
| 2015 FY | 51.33 Million USD | 5389.84% |
| 2014 FY | 935 Thousand USD | 121.85% |
| 2014 Q4 | 7.09 Million USD | 879.34% |
| 2014 Q3 | -910 Thousand USD | 23.59% |
| 2014 Q2 | -1.19 Million USD | -5078.26% |
| 2014 Q1 | -23 Thousand USD | 97.25% |
| 2013 Q1 | -25.07 Million USD | -12.32% |
| 2013 Q4 | -835 Thousand USD | 49.85% |
| 2013 Q3 | -1.66 Million USD | -53.46% |
| 2013 Q2 | -1.08 Million USD | 95.67% |
| 2013 FY | -4.28 Million USD | -103.35% |
| 2012 FY | 127.6 Million USD | 420.58% |
| 2012 Q1 | 127.09 Million USD | 2270.37% |
| 2012 Q3 | -25.59 Million USD | -1889.93% |
| 2012 Q4 | -22.32 Million USD | 12.79% |
| 2012 Q2 | 1.43 Million USD | -98.87% |
| 2011 Q2 | 6.38 Million USD | 0.92% |
| 2011 Q3 | 6.43 Million USD | 0.66% |
| 2011 Q4 | 5.36 Million USD | -16.62% |
| 2011 FY | 24.51 Million USD | 1.19% |
| 2011 Q1 | 6.33 Million USD | -8.8% |
| 2010 Q1 | 5.71 Million USD | 49.5% |
| 2010 Q4 | 6.94 Million USD | 30.93% |
| 2010 Q3 | 5.3 Million USD | -15.36% |
| 2010 FY | 24.22 Million USD | -0.62% |
| 2010 Q2 | 6.26 Million USD | 9.63% |
| 2009 FY | 24.37 Million USD | 5.53% |
| 2009 Q4 | 3.82 Million USD | -30.7% |
| 2009 Q2 | 5.49 Million USD | -42.45% |
| 2009 Q1 | 9.54 Million USD | 60.48% |
| 2009 Q3 | 5.51 Million USD | 0.4% |
| 2008 FY | 23.09 Million USD | 4.97% |
| 2008 Q1 | 5.64 Million USD | 0.27% |
| 2008 Q4 | 5.94 Million USD | -0.87% |
| 2008 Q3 | 5.99 Million USD | 8.97% |
| 2008 Q2 | 5.5 Million USD | -2.48% |
| 2007 Q3 | 5.66 Million USD | 6.86% |
| 2007 FY | 22 Million USD | 12.33% |
| 2007 Q2 | 5.3 Million USD | -1.72% |
| 2007 Q4 | 5.63 Million USD | -0.69% |
| 2007 Q1 | 5.39 Million USD | 9.49% |
| 2006 FY | 19.58 Million USD | 62.49% |
| 2006 Q4 | 4.93 Million USD | -10.75% |
| 2006 Q1 | 4.29 Million USD | 27.18% |
| 2006 Q2 | 4.83 Million USD | 12.59% |
| 2006 Q3 | 5.52 Million USD | 14.2% |
| 2005 Q1 | 2.75 Million USD | 0.62% |
| 2005 Q3 | 3 Million USD | 3.19% |
| 2005 FY | 12.05 Million USD | 34.83% |
| 2005 Q4 | 3.37 Million USD | 12.38% |
| 2005 Q2 | 2.91 Million USD | 5.66% |
| 2004 Q2 | 1.78 Million USD | 0.0% |
| 2004 Q3 | 2.63 Million USD | 47.98% |
| 2004 Q4 | 2.74 Million USD | 3.91% |
| 2004 FY | 8.94 Million USD | 147.99% |
| 2003 FY | 3.6 Million USD | 2210.9% |
| 2002 FY | 156 Thousand USD | 0.0% |
| 2001 FY | - USD | 100.0% |
| 2000 FY | -43.18 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 82.801% |
| AlloVir, Inc. | -398 Thousand USD | 65694.221% |
| Aptorum Group Limited | -1.11 Million USD | 23520.455% |
| Ardelyx, Inc. | 106.66 Million USD | -144.761% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -8.445% |
| Bicycle Therapeutics plc | -129.52 Million USD | 301.563% |
| AbCellera Biologics Inc. | 38.02 Million USD | -586.561% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -217454.167% |
| Chimerix, Inc. | 324 Thousand USD | -80475.617% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 937.615% |
| Elevation Oncology, Inc. | -39 Thousand USD | 669497.436% |
| Alkermes plc | 1.37 Billion USD | 81.009% |
| Fortress Biotech, Inc. | 57.85 Million USD | -351.256% |
| Fortress Biotech, Inc. | 57.85 Million USD | -351.256% |
| Agenus Inc. | 139.61 Million USD | -86.989% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1474.863% |
| Dyadic International, Inc. | 922.95 Thousand USD | -28185.716% |
| ImmuCell Corporation | 4.39 Million USD | -5838.311% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -1139.566% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 346.002% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 149413.956% |
| Immix Biopharma, Inc. | -5468.00 USD | 4774514.777% |
| Incyte Corporation | 3.44 Billion USD | 92.412% |
| IO Biotech, Inc. | -756 Thousand USD | 34632.407% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 657.367% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 2054.394% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 590905.196% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 365.804% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 39417.018% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 474763.636% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 5221400.0% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -118.003% |
| ContextLogic Inc. | 59 Million USD | -342.483% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -32451.746% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 49637.951% |
| MiMedx Group, Inc. | 266.84 Million USD | 2.165% |
| MEI Pharma, Inc. | 49.32 Million USD | -429.254% |
| Novavax, Inc. | 639.93 Million USD | 59.205% |
| NextCure, Inc. | -3.68 Million USD | 7186.455% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1270.924% |
| Onconetix, Inc. | -1.12 Million USD | 23261.205% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 1001.219% |
| Opthea Limited | 21.72 Thousand USD | -1201856.722% |
| Psyence Biomedical Ltd. | -240.00 USD | 108777183.333% |
| Vaxcyte, Inc. | -75 Million USD | 448.087% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 455504.18% |
| Precigen, Inc. | 106 Thousand USD | -246187.736% |
| Pharming Group N.V. | 220.1 Million USD | -18.61% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -50592.233% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -25773.637% |
| PureTech Health plc | -1.6 Million USD | 16386.026% |
| Pyxis Oncology, Inc. | -2 Million USD | 13153.25% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -137.825% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 243.91% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 50620.952% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | -3615.17% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 675.985% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1287.361% |
| Acelyrin, Inc. | -115 Thousand USD | 227113.043% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 2597503.243% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 45820.665% |
| Senti Biosciences, Inc. | -2.68 Million USD | 9830.339% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -3216.796% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -6344.458% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 5541.121% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 6722.573% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -796.237% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -52534.073% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -61471.934% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 318471.951% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -150.785% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -92.997% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 369.278% |
| ChromaDex Corporation | 50.78 Million USD | -414.11% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -788.369% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 112628.017% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 53161.992% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 436.433% |
| CRISPR Therapeutics AG | 240.95 Million USD | -8.346% |
| Precision BioSciences, Inc. | 40.47 Million USD | -545.051% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 365.951% |
| Jaguar Health, Inc. | 7.72 Million USD | -3279.92% |
| Summit Therapeutics Inc. | -2.05 Million USD | 12834.878% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -5863.111% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -1111.72% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 220424.75% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 182279.468% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -42767.816% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -116.698% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 16.771% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -10042.385% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 514615.175% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 3778.008% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 55113.75% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 2510340.385% |
| Soligenix, Inc. | 97.31 Thousand USD | -268179.023% |
| Century Therapeutics, Inc. | -10.8 Million USD | 2515.256% |
| Kura Oncology, Inc. | -849 Thousand USD | 30849.706% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 489.045% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 177695.238% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -163.598% |
| Autolus Therapeutics plc | -4.86 Million USD | 5463.982% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -530.805% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 155495.833% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -175.609% |
| GRI Bio, Inc. | 10.84 Million USD | -2308.127% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -10178.206% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 3105.238% |
| IGM Biosciences, Inc. | -211.66 Million USD | 223.342% |
| INmune Bio, Inc. | 155 Thousand USD | -168329.032% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -321.487% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 17431.644% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 40359.602% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 891898.183% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -64841.542% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 13179.409% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 83507.348% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -176.373% |
| Verastem, Inc. | -62 Thousand USD | 421172.581% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -10621.355% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 100124.904% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -8524.546% |
| Histogen Inc. | 3.76 Million USD | -6826.638% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -45209.704% |
| Surrozen, Inc. | -27.23 Million USD | 1058.74% |
| Organovo Holdings, Inc. | -5.38 Million USD | 4944.405% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 21767.303% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 1117.916% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1201.94% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 13185201.01% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -4203.442% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 388988.889% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -68.656% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -178956.927% |
| Apollomics, Inc. | 127 Thousand USD | -205462.992% |
| Amarin Corporation plc | 165.54 Million USD | -57.704% |
| Mesoblast Limited | -9.81 Million USD | 2759.857% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1481.637% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 336.281% |
| Synaptogenix, Inc. | -6347.00 USD | 4113303.088% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 511992.157% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -61.785% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 85.147% |
| Better Therapeutics, Inc. | -2.72 Million USD | 9666.325% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 332.759% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 22.78% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2288537.938% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 4270.367% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 23661.823% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -3467.436% |
| Insmed Incorporated | 239.63 Million USD | -8.943% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -7196.395% |
| OmniAb, Inc. | 14.66 Million USD | -1679.948% |
| Alector, Inc. | -95.05 Million USD | 374.652% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -107.82% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 700.66% |
| Zai Lab Limited | 170.9 Million USD | -52.756% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -218.85% |
| Aura Biosciences, Inc. | -1.29 Million USD | 20259.459% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -200719.231% |
| Immunic, Inc. | -111 Thousand USD | 235293.694% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1546.682% |
| Veracyte, Inc. | 248.14 Million USD | -5.205% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 103.735% |
| FibroGen, Inc. | 128.9 Million USD | -102.527% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 46288220.567% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 2337.658% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 92.319% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -67011.825% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 26.532% |
| TG Therapeutics, Inc. | 219.1 Million USD | -19.149% |
| Galecto, Inc. | -830 Thousand USD | 31553.614% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 18949.458% |
| Fortrea Holdings Inc. | 424 Million USD | 38.428% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 402.976% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 46143.21% |
| XBiotech Inc. | -1.74 Million USD | 15069.323% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 23661.823% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 661.78% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 445.626% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -255.66% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1453.681% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 32.895% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 625.842% |
| Vaxxinity, Inc. | -2.23 Million USD | 11785.989% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 20.103% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 2405.445% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -967.707% |
| NexImmune, Inc. | -1.02 Million USD | 25570.452% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -4834437.037% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 3774.045% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 97.69% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 390757.968% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 7451.873% |
| Ainos, Inc. | -253.73 Thousand USD | 102989.652% |
| Pluri Inc. | 322 Thousand USD | -80976.087% |
| Prothena Corporation plc | -129.2 Million USD | 302.061% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -417.74% |
| Celularity Inc. | 6.75 Million USD | -3764.767% |
| Rallybio Corporation | -150 Thousand USD | 174143.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 900.641% |
| MeiraGTx Holdings plc | 287 Thousand USD | -90863.415% |
| Omeros Corporation | -69.77 Million USD | 474.131% |
| Humacyte, Inc. | -76.55 Million USD | 441.039% |
| Immunocore Holdings plc | 248.39 Million USD | -5.102% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1821.043% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -318.494% |
| Blueprint Medicines Corporation | 236.58 Million USD | -10.348% |
| CalciMedica, Inc. | -58 Thousand USD | 450212.069% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 18407.504% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -798.52% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 9279.501% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 945.829% |
| Pulmatrix, Inc. | -8.22 Million USD | 3275.973% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 22413.248% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 65529.825% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 165.464% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -9305.765% |
| Cytokinetics, Incorporated | -322.59 Million USD | 180.927% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -30182.274% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 76658.651% |
| Vor Biopharma Inc. | -3.49 Million USD | 7576.088% |
| Roivant Sciences Ltd. | 109.23 Million USD | -138.994% |
| Evogene Ltd. | 1.39 Million USD | -18560.829% |
| ProKidney Corp. | -3.16 Million USD | 8338.088% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 694.519% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -3707.277% |
| CorMedix Inc. | -205.56 Thousand USD | 127100.613% |
| BioLineRx Ltd. | 1.1 Million USD | -23461.823% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 431.844% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 791206.061% |
| Atai Life Sciences N.V. | -5000.00 USD | 5221400.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 214335.305% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 272042.708% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 18895.176% |
| Sagimet Biosciences Inc. | 2 Million USD | -12953.25% |
| MediciNova, Inc. | 979.7 Thousand USD | -26547.307% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 409.616% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 276198.567% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1359.92% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -6.76% |
| Biomea Fusion, Inc. | -4.2 Million USD | 6314.354% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 70.073% |
| Mereo BioPharma Group plc | 7.42 Million USD | -3415.553% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 84314.516% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 2175641.667% |
| Absci Corporation | -41.84 Million USD | 723.826% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 5221400.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 441.829% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 10708.086% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -22.144% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 27843.358% |
| Allakos Inc. | -6.14 Million USD | 4351.181% |
| Imunon, Inc. | -720 Thousand USD | 36358.776% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 478.377% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 45.142% |
| BioAtla, Inc. | -103.73 Million USD | 351.675% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2288537.938% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 146765.73% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 207.514% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 84043.73% |
| XOMA Corporation | 3.86 Million USD | -6661.59% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 472.498% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1664.668% |
| aTyr Pharma, Inc. | -2.38 Million USD | 11032.37% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1995.225% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 900324.138% |
| Viridian Therapeutics, Inc. | -1 Million USD | 25999.306% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -2008192207.692% |
| Akari Therapeutics, Plc | -4000.00 USD | 6526725.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 59.01% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -133980.264% |
| UroGen Pharma Ltd. | 73.35 Million USD | -255.907% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 1077.991% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -2248521.878% |
| Orgenesis Inc. | -5.72 Million USD | 4660.087% |
| Entera Bio Ltd. | -56 Thousand USD | 466287.5% |
| GH Research PLC | -315 Thousand USD | 82977.778% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 138229.63% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 49826.667% |
| Xencor, Inc. | -85.26 Million USD | 406.199% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 118241.255% |
| Replimune Group, Inc. | -2.65 Million USD | 9932.957% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 26174.272% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -46.794% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -133980.264% |
| Portage Biotech Inc. | -54 Thousand USD | 483553.704% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 276198.567% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 69348.011% |
| OncoCyte Corporation | 413 Thousand USD | -63111.864% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 5807997.664% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 117596946.847% |
| Purple Biotech Ltd. | -196 Thousand USD | 133296.429% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -2811.073% |
| scPharmaceuticals Inc. | 9.78 Million USD | -2568.831% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 2599.436% |
| HilleVax, Inc. | -2.15 Million USD | 12208.766% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 269239.175% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1740069.342% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 39181.587% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1135165.217% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 3478110.061% |
| Savara Inc. | -44.26 Million USD | 689.817% |
| Curis, Inc. | 9.81 Million USD | -2560.942% |
| Daré Bioscience, Inc. | 2.76 Million USD | -9326.356% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 209306.815% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 15199.19% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 114602.193% |
| BeiGene, Ltd. | 2.07 Billion USD | 87.442% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 9437.423% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 165.321% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -360.53% |
| Erasca, Inc. | -3.73 Million USD | 7095.311% |
| bluebird bio, Inc. | -4.03 Million USD | 6578.04% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 925271.876% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 86.291% |
| DBV Technologies S.A. | 15.72 Million USD | -1559.874% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 925271.876% |
| Moderna, Inc. | 2.15 Billion USD | 87.886% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 28631.694% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -3160.867% |
| Molecular Templates, Inc. | 50.39 Million USD | -418.038% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 48806.157% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -95.133% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 4295.837% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 763.561% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 334.923% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 7376.059% |
| MacroGenics, Inc. | 50.52 Million USD | -416.684% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 4381.158% |
| Prime Medicine, Inc. | -147.9 Million USD | 276.509% |
| Aditxt, Inc. | -111.66 Thousand USD | 233903.511% |
| Adagene Inc. | 18.11 Million USD | -1341.433% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -53396.926% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -86.206% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -65.403% |
| SciSparc Ltd. | 2.19 Million USD | -11788.206% |
| Vericel Corporation | 135.57 Million USD | -92.56% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1042317.254% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 842734.433% |
| Generation Bio Co. | -73.91 Million USD | 453.215% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 59840.275% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -377.975% |
| Invivyd, Inc. | -2.02 Million USD | 12973.028% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 186.778% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 252487.904% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -170.904% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -165.612% |
| ADMA Biologics, Inc. | 88.21 Million USD | -195.932% |
| Clene Inc. | 533 Thousand USD | -48880.3% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -982.845% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 27379.519% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1359.92% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -13032.042% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 134450.748% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -424.174% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 3781.12% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 31327.871% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -212.971% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -356975.446% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -391.074% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 250.741% |
| Trevena, Inc. | 1.45 Million USD | -17842.612% |
| Surrozen, Inc. | -27.23 Million USD | 1058.74% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 74056.091% |
| Cingulate Inc. | -582.91 Thousand USD | 44885.888% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 842245.161% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1425.27% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 3448778.996% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 29732.804% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 61.648% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 26523.583% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 463457.708% |
| Kronos Bio, Inc. | 1.37 Million USD | -18928.061% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 586.463% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 89505.822% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 53562.526% |
| ImmunityBio, Inc. | -17.89 Million USD | 1559.279% |
| Korro Bio, Inc. | -3.63 Million USD | 7291.873% |
| Kineta, Inc. | 5.43 Million USD | -4705.172% |
| BioVie Inc. | -229.37 Thousand USD | 113914.811% |
| Codexis, Inc. | 57.33 Million USD | -355.341% |
| Celularity Inc. | 6.75 Million USD | -3764.767% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -6405.482% |
| Celcuity Inc. | -142.77 Thousand USD | 182954.481% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -515940.72% |
| Cibus, Inc. | 1.42 Million USD | -18259.001% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 69903.476% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1239.077% |
| IN8bio, Inc. | -2.5 Million USD | 10538.425% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1106.147% |
| Annexon, Inc. | -3.26 Million USD | 8090.97% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 12872.26% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 725.5% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -40691.406% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 66.466% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -50.944% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 13840.263% |
| Arcellx, Inc. | 108.27 Million USD | -141.104% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 906.528% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -229.611% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1334.233% |
| Moolec Science SA | -143.3 Thousand USD | 182274.383% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 716.912% |
| Geron Corporation | -123.5 Million USD | 311.384% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -7842.349% |
| Royalty Pharma plc | 1.79 Billion USD | 85.447% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 472.471% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 7227813.178% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -112724.181% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 334.32% |
| Humacyte, Inc. | -76.55 Million USD | 441.039% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 27604.441% |
| 89bio, Inc. | -273 Thousand USD | 95728.205% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 20868.894% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 30885.967% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 212347.967% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -23230.206% |
| Notable Labs, Ltd. | 113 Thousand USD | -230930.973% |
| Liquidia Corporation | 14.6 Million USD | -1688.116% |
| Mustang Bio, Inc. | -2.22 Million USD | 11833.258% |
| Immunovant, Inc. | -231 Thousand USD | 113115.152% |
| Quantum-Si incorporated | 488 Thousand USD | -53396.926% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 569.888% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 870316.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -13920.677% |
| Acasti Pharma Inc. | -11 Thousand USD | 2373418.182% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 127687.151% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 40359.602% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 255.849% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -22909.836% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 68620.997% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 13433.248% |
| PepGen Inc. | -1.18 Million USD | 22149.409% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 205662.992% |
| United Therapeutics Corporation | 2.07 Billion USD | 87.388% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1240.171% |
| Solid Biosciences Inc. | -76.56 Million USD | 440.981% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 316224.384% |
| Immuneering Corporation | -764.13 Thousand USD | 34264.64% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -393877.122% |
| Belite Bio, Inc | -399 Thousand USD | 65529.825% |
| XOMA Corporation | 3.86 Million USD | -6661.59% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1402.98% |
| Bionomics Limited | -434.44 Thousand USD | 60191.058% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 24407.728% |
| uniQure N.V. | 2.21 Million USD | -11686.23% |
| Cassava Sciences, Inc. | -89.42 Million USD | 391.944% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 383.554% |
| Forte Biosciences, Inc. | -9000.00 USD | 2900822.222% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 31365.269% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 59840.275% |
| Altimmune, Inc. | -65.37 Million USD | 499.347% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 27.889% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 24407.728% |
| Compugen Ltd. | 31.45 Million USD | -729.963% |
| Peak Bio, Inc. | 367.76 Thousand USD | -70886.135% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -964.876% |
| Benitec Biopharma Inc. | 108 Thousand USD | -241626.852% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 334798.718% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 21801.164% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 14428.485% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 219482.353% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 21801.164% |
| Instil Bio, Inc. | -4.75 Million USD | 5589.172% |
| argenx SE | 1.1 Billion USD | 76.448% |
| Immunome, Inc. | -8.9 Million USD | 3031.009% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 13912.963% |
| Verona Pharma plc | -679.62 Thousand USD | 38513.152% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 149280.0% |
| Shattuck Labs, Inc. | -2.38 Million USD | 11046.122% |
| CervoMed Inc. | -1.29 Million USD | 20280.856% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 10946.074% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 5565.041% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -10465.156% |
| Moolec Science SA | -143.3 Thousand USD | 182274.383% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 64081.815% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 9872.123% |
| AnaptysBio, Inc. | 14.78 Million USD | -1666.22% |
| Design Therapeutics, Inc. | -537 Thousand USD | 48715.456% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 61239.344% |
| NeurAxis, Inc. | 2.15 Million USD | -12004.814% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -12065.191% |
| Lumos Pharma, Inc. | 2 Million USD | -12907.723% |
| Achilles Therapeutics plc | -4.73 Million USD | 5617.867% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 149280.0% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 247145.186% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -724.622% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -30182.274% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 25396.996% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 673.165% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -607027.907% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 31859.732% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1984178.127% |
| Palisade Bio, Inc. | 246 Thousand USD | -106023.984% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 791206.061% |
| Beam Therapeutics Inc. | -59.67 Million USD | 537.5% |
| Neurogene Inc. | -3.26 Million USD | 8103.219% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -87.365% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 7171.1% |
| Sesen Bio, Inc. | 40 Million USD | -552.663% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 88000.673% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 6582.806% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 2829.093% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1754.155% |
| Athira Pharma, Inc. | -969 Thousand USD | 27041.692% |
| Vaccinex, Inc. | -16 Million USD | 1731.248% |
| HCW Biologics Inc. | -574.82 Thousand USD | 45516.51% |
| XOMA Corporation | 3.86 Million USD | -6661.59% |
| Nektar Therapeutics | 53.47 Million USD | -388.173% |
| Arvinas, Inc. | 71.8 Million USD | -263.6% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 412.799% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 515.874% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 81176.087% |
| Rezolute, Inc. | -36 Thousand USD | 725280.556% |
| Clene Inc. | 533 Thousand USD | -48880.3% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 20332265.109% |
| BeyondSpring Inc. | 1.75 Million USD | -14809.48% |
| Synlogic, Inc. | -1.92 Million USD | 13668.867% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 705681.081% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 4222.947% |
| Peak Bio, Inc. | 367.76 Thousand USD | -70886.135% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1476.707% |
| Krystal Biotech, Inc. | 47.6 Million USD | -448.398% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -85.033% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -5095.323% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 10182.77% |
| MannKind Corporation | 136.19 Million USD | -91.69% |
| Ikena Oncology, Inc. | -50.49 Million USD | 617.042% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -139.919% |
| Gossamer Bio, Inc. | -4.38 Million USD | 6053.592% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 103697.222% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 5221400.0% |
| Legend Biotech Corporation | 140.92 Million USD | -85.246% |
| Mural Oncology plc | -2.56 Million USD | 10270.043% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 47480.218% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 261165.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -1157.902% |
| REGENXBIO Inc. | 53.02 Million USD | -392.306% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 4973.386% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 135806.303% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 15173.037% |
| Vaxart, Inc. | -60.76 Million USD | 529.645% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 99447.363% |
| Cellectis S.A. | 18 Thousand USD | -1450261.111% |
| Longeveron Inc. | 221 Thousand USD | -118028.959% |
| Repare Therapeutics Inc. | -80.07 Million USD | 426.046% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 76.115% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 20275.039% |
| Revolution Medicines, Inc. | -399.66 Million USD | 165.321% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 746000.0% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -532685.714% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 96.967% |
| Denali Therapeutics Inc. | -93.34 Million USD | 379.678% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1042317.254% |
| Veru Inc. | 7.56 Million USD | -3350.535% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 172990.728% |
| Cingulate Inc. | -582.91 Thousand USD | 44885.888% |
| Passage Bio, Inc. | -3.72 Million USD | 7115.99% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 2167693.823% |
| Exicure, Inc. | -1.42 Million USD | 18446.1% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 68263.185% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -9558.343% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 51022.124% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -283.209% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 174600.525% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 540.943% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -66668.542% |
| OmniAb, Inc. | 14.66 Million USD | -1679.948% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1205.782% |
| Lipocine Inc. | -2.85 Million USD | 9257.547% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 14265.22% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 4676.074% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 17431.644% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -246.626% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 401738.462% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -209.7% |
| Ocugen, Inc. | -33.53 Million USD | 878.439% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 8356.325% |
| Q32 Bio Inc. | 578 Thousand USD | -45066.955% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 98615.094% |
| Alumis Inc. Common Stock | -1.28 Million USD | 20432.165% |
| Equillium, Inc. | 35.95 Million USD | -626.028% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 15393.79% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -52042.191% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 6315170.15% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 100897.297% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -61659.543% |
| Dominari Holdings Inc. | 2.03 Million USD | -12703.58% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 142392.242% |
| vTv Therapeutics Inc. | -13.59 Million USD | 2020.302% |
| Bio-Techne Corporation | 773.07 Million USD | 66.23% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1407.391% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 43.344% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 22432.335% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1188.678% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -2131.897% |
| Nkarta, Inc. | -5.86 Million USD | 4548.202% |
| BioCardia, Inc. | -7.24 Million USD | 3701.393% |
| Iterum Therapeutics plc | -1.75 Million USD | 15018.0% |